• Magazine
    • Past Issues
    • Subscribe
    • Change Mailing Address
    • Surveys
    • Guidelines for Authors
    • Editorial Calendar
    • Editorial Deadlines
  • Practice
    • Business Tips
    • Chiropractic Schools
    • Clinical & Technique
    • eBooks
    • eCourses
    • Infographics
    • Quizzes
    • Wellness & Nutrition
    • Personal Growth
    • Podcast
  • Resource Centers
  • Products & Services
    • Buyer’s Guide
    • Products Directory
    • Submit a Product
    • Vendor Login
  • Datebook
    • Become an Events Poster
    • Post an Event
    • View Events
  • Jobs
    • Jobs
    • Post a Job
  • Advertise
    • Advertising Information
    • Media Kit
    • Contact Us
    • Upload Advertising

Your Online Chiropractic Community

Chiropractic Economics Your Online Chiropractic Community
Subscribe
  • Home
  • Current Issue
  • News
  • Webinars
  • Chiropractic Research
  • Students
  • Coronavirus (COVID-19)

Metagenics awarded 2 new patents for hops-derived anti-inflammatory compositions

Chiropractic Economics October 31, 2010

October 29, 2010 — Metagenics Inc. has been awarded two new patents for discoveries relating to its research on the anti-inflammatory properties of reduced iso-alpha acids (RIAA) derived from hops.

Metagenics is a life sciences company focused on reversing chronic illness and improving health through therapeutic nutrition and lifestyle changes. The discoveries were made by researchers at Metagenics’ wholly-owned biotechnology subsidiary, MetaProteomics LLC.

U.S. Patent No. 7,794,757, “Modulation of Inflammation by Hops Fractions and Derivatives,” was awarded for a proprietary method to reduce inflammation associated with pain using a formulation of hops derivatives that selectively inhibits the pro-inflammatory activities of the COX-2 enzyme without affecting the housekeeping activities of COX-2 (protection of the gastrointestinal lining), thus providing effective anti-inflammatory support with high degrees of predicted safety.

U.S. Patent No. 7,807,203, “Anti-inflammatory Pharmaceutical Compositions for Reducing Inflammation and the Treatment or Prevention of Gastric Toxicity” was awarded for the application of a proprietary formulation of hops in preventing or treating disorders of the stomach and/or intestines that can lead to ulcers.

Inflammation is recognized as underlying factor in a wide range of chronic health conditions, including osteoarthritis, ulcers, autoimmune disease, low bone mineral density, and metabolic syndrome.

Rho iso-alpha acids derived from hops, say the researchers, modulate enzymes called kinases. Kinases perform a variety of tasks, including chemically modifying other proteins, regulating cellular pathways (particularly those involved in the transmission of signals within the cell), and regulating substances that can negatively impact health, including eicosanoids, cytokines, and free radicals.

“We believe that our research opens the door to a new class of therapeutic agents that address inflammatory-related conditions at the cellular level” said Jeffrey S. Bland, PhD, FACN, Metagenics chief science officer and president of MetaProteomics.

Source: Metagenics Inc., www.metagenics.com

 

Related Posts

  • Metagenics’ research published in journalMetagenics’ research published in journal
  • BioCell Collagen wins Better Nutrition’s 2015 Best of Supplements AwardBioCell Collagen wins Better Nutrition’s 2015 Best of Supplements Award
  • Jeffrey Bland, Metagenics form Personalized Lifestyle Medicine InstituteJeffrey Bland, Metagenics form Personalized Lifestyle Medicine Institute
  • Metagenics’ CSO inducted into New Hope Natural Media 2012 Hall of LegendsMetagenics’ CSO inducted into New Hope Natural Media 2012 Hall of Legends
  • Douglas Laboratories obtains exclusive distribution rights of Corvalen D-RiboseDouglas Laboratories obtains exclusive distribution rights of Corvalen D-Ribose
  • BioSignia, PatientCentral Technologies join forcesBioSignia, PatientCentral Technologies join forces

Filed Under: Industry News, News

Current Issue

Follow Us

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube logoYouTube logoYouTube

820 A1A N Highway W18,

Ponte Vedra Beach, FL 32082

Phone 904.285.6020

Fax 904.395.9118

CONTACT US »

Privacy Policy & Terms of Service

Copyright © 2021, All Rights Reserved

SUBSCRIBE TO THE MAGAZINE

Get Chiropractic Economics magazine
delivered to your home or office. Just
fill out our form to request your FREE
subscription for 20 issues a year,
including two annual Buyers Guides.

SUBSCRIBE NOW »

Latest Chiropractic News

  • MediHerb® introduces Ashwagandha Forte for patient sleep, stress, immunity support
  • HealthLight expands to include blue light therapy for chiropractors
  • Chiropractic student scholarships awarded by National Board of Chiropractic Examiners
x